Relationship Between IL-۲, IL-۱۷ Concentrations, and Serum Creatinine Levels in Men with Chronic Kidney Diseases

Publish Year: 1400
نوع سند: مقاله ژورنالی
زبان: English
View: 168

This Paper With 11 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_RBMB-10-4_016

تاریخ نمایه سازی: 25 بهمن 1400

Abstract:

Background: Chronic kidney disease (CKD), is a major public health challenge worldwide. It is more prevalent in developed countries compared with the rest of the world, due to the higher rates of life expectancy and unhealthy lifestyle related factors. This aim of the current study is to evaluate the relationship between interleukins IL-۲ and IL-۱۷ concentrations and kidney function markers in men with CKD. Methods: Forty-five men with CKD and seventy controls were enrolled in the current study to assess the relationship between interleukin-۲ (IL-۲), interleukin-۱۷ (IL-۱۷), and CKD parameters. Fasting blood samples were collected from patients with CKD and their controls at same time. Serum IL-۲, and IL-۱۷ were measured in patients with CKD and their controls, and then the relationship between these interleukins and serum creatinine, serum urea, serum uric acid and urine albumin were evaluated. Results: A significant relationship was detected between IL-۲ (p< ۰.۰۰۱), IL-۱۷ (p< ۰.۰۰۱) levels and serum creatinine concentrations. The significant increase of IL-۲ and IL-۱۷ levels were also paralleled with a significant increase in serum urea (p< ۰.۰۰۱), and urine albumin (p< ۰.۰۰۱) concentrations respectively. Conclusions: IL-۲ and IL-۱۷ may play a critical role in the pathophysiology of CKD. The significant increase of IL-۲ and IL-۱۷ is associated with significantly high concentrations of creatinine, serum urea and urine albumin suggesting that these interleukins may be used as targets for future biomarkers and molecular therapy. However, due to limited sample size of the current study, larger prospective cohorts are needed to confirm these observations.

Authors

Khalid Farouq Al-rawi

Department of Chemistry, College of Science, University of Anbar, Al-anbar Province, Iraq.

Hameed H. Ali

Department of Chemistry, College of Science, University of Anbar, Al-anbar Province, Iraq.

Manaf Abdulrahman Guma

Department of Applied Chemistry, College of Applied Sciences, University of Anbar, Al-anbar Province, Iraq.

Bilal Jasir Mohammed Aldahham

Department of Applied Chemistry, College of Applied Sciences, University of Anbar, Al-anbar Province, Iraq.

Shakir Faris Tuleab Alaaraji

Department of Chemistry, College of Education for pure Science, University of Anbar, Al-anbar Province, Iraq.

Osamah Al-ani

Yarmouk Academic Hospital, Baghdad, Iraq.

Aus Tariq Ali

University of Anbar, Al-anbar Province, Iraq.

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Jager KJ, Kovesdy C, Langham R, Rosenberg M, Jha V, ...
  • Akchurin OM, Kaskel F. Update on inflammation in chronic kidney ...
  • Foreman KJ, Marquez N, Dolgert A, Fukutaki K, Fullman N, ...
  • Ricardo AC, Anderson CA, Yang W, Zhang X, Fischer MJ, ...
  • Bleyer AJ, Shemanski LR, Burke GL, Hansen KJ, Appel RG. ...
  • Yamagata K, Ishida K, Sairenchi T, Takahashi H, Ohba S, ...
  • Collaborators GRFS. Global regional and national comparative risk assisment of ...
  • Kim MG, Kim SC, Ko YS, Hee YL, Jo SK, ...
  • Kon V, Linton MRF, Fazio S. Atherosclerosis in chronic kidney ...
  • Levey AS, Beto JA, Coronado BE, Eknoyan G, Foley RN, ...
  • Carrero JJ, Park SH, Axelsson J, Lindholm B, Stenvinkel P. ...
  • Silverstein DM. Inflammation in chronic kidney disease: role in the ...
  • Koelman L, Pivovarova-Ramich O, Pfeiffer AFH, Grune T, Aleksandrova K. ...
  • Mittal RD, Manchanda PK. Association of interleukin (IL)-۴ intron-۳ and ...
  • Fasoulakis Z, Kolios G, Papamanolis V, Kontomanolis EN. Interleukins associated ...
  • Kellum JA, Sileanu FE, Bihorac A, Hoste EA, Chawla LS. ...
  • Traynor J, Mactier R, Geddes CC, Fox JG. How to ...
  • Nickolas TL, Barasch J, Devarajan P. Biomarkers in acute and ...
  • Ortiz A, Covic A, Fliser D, Fouque D, Goldsmith D, ...
  • Lang J, Katz R, IX JH, Gutierrez OM, Peralta CA, ...
  • Forni LG, Darmon M, Ostermann M, Straaten HM O-V, Pettilä ...
  • Simerville JA, Maxted WC, Pahira JJ. Urinalysis: A comprehensive review. ...
  • Levin A, Stevens PE, Bilous RW, Coresh J, De Francisco ...
  • Johnson RJ, Nakagawa T, Jalal D, Sánchez-Lozada LG, Kang DH, ...
  • Stenvinkel P, Alvestrand A. Inflammation in end-stage renal disease: sources, ...
  • Zickert A, Amoudruz P, Sundström Y, Rönnelid J, Malmström V, ...
  • Mohammadi M, Gozashti MH, Aghadavood M, Mehdizadeh MR, Hayatbakhsh MM. ...
  • Raghunathachar Sahana K, Akila P, Prashant V, Sharath Chandra B, ...
  • Lee BT, Ahmed FA, Lee Ham L, Teran FJ, Chen ...
  • Stenvinkel P, Ketteler M, Johnson RJ, Lindholm B, Pecoits-Filho R, ...
  • Tamura MK. Incidence, management, and outcome of end-stage renal disease ...
  • Hallan S I, Matsushita K, Sang Y, Mahmoodi BK, Black ...
  • Nitta K, Okada K, Yanai M, Takahashi S. Aging and ...
  • De Nicola L, Minutolo R, Chiodini P, Borrelli S, Zoccali ...
  • Derhaschnig U, Kittler H, Woisetschlager C, Bur A, Herkner H, ...
  • Pugia MJ, Murakami M, Lott JA, Ohta Y, Kitagawa T, ...
  • Imai E, Yamagata K, Iseki K, Iso H, Horio M, ...
  • Salazar JH. Overview of urea and creatinine. Lab Medicine ۲۰۱۴; ...
  • Lyman JL. Blood urea nitrogen and creatinine. Emerg Med Clin ...
  • Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S. The pro-and ...
  • ERA-EDTA Council; ERACODA Working Group. Chronic kidney disease is a ...
  • نمایش کامل مراجع